Unique ID issued by UMIN | UMIN000008369 |
---|---|
Receipt number | R000009834 |
Scientific Title | An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes |
Date of disclosure of the study information | 2012/07/06 |
Last modified on | 2020/04/05 21:07:43 |
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
To compare the pleiotropic effects including glucose metabolism on patients with type 2 Diabetes between Bolus First (insulin aspart three times daily) and Basal First Insulin (insulin detemir at bedtime)
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
M values
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
Central registration
2
Treatment
Medicine |
insulin aspart three times daily
insulin detemir at bedtime
20 | years-old | <= |
Not applicable |
Male and Female
1)Type 2 diabetes
2)HbA1c >=7.4%
1)Patients with allergies to insulin aspart or detemir
2)None type 2 diabetes
3)Medical history and/or complication of diabetic ketoacidosis
4)Medical history and/or complication of severe hypoglycemia
5)Treatment with insulin, DPP-4 inhibitor or GLP-1 analogue within 4 weeks prior to the study
6)Treatment with glucocorticoid
7)Uncontrolled hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
8)Patients with proliferative retinopathy or maculopathy
9)Medical history and/or malignancy
10)Severe complications and problems not suitable for the study
11)Pregnant or lactating women
40
1st name | Toshinari |
Middle name | |
Last name | TAKAMURA |
Kanazawa University Graduate School of Medical Sciences
Department of Disease Control and Homeostasis
920-8641
13-1 Takara-machi, Kanazawa, Ishikawa, Japan
076-265-2234
ttakamura@med.kanazawa-u.ac.jp
1st name | YUMIE |
Middle name | |
Last name | Takeshita |
Kanazawa University Graduate School of Medical Sciences
Department of Disease Control and Homeostasis
920-8641
13-1 Takara-machi, Kanazawa, Ishikawa, Japan
076-265-2234
takeshita@m-kanazawa.jp
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
Self funding
kanazawa university
13-1 takaramachi
076-265-2049
t-isomu@adm.kanazawa-u.ac.jp
NO
金沢大学附属病院(石川県)
2012 | Year | 07 | Month | 06 | Day |
Published
38
Completed
2010 | Year | 08 | Month | 18 | Day |
2010 | Year | 09 | Month | 09 | Day |
2010 | Year | 08 | Month | 01 | Day |
2012 | Year | 11 | Month | 30 | Day |
2012 | Year | 07 | Month | 06 | Day |
2020 | Year | 04 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009834
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |